Please find the session links next to their corresponding agenda item.


Tuesday, December 8


FDLI Welcome and Introduction
Amy Comstock Rick, President & CEO, FDLI


Fireside Chat with FDA
Joseph Franklin, Policy Director for the Principal Deputy Commissioner, FDA
Interviewed by Suzie Loonam Trigg, Partner, Haynes and Boone LLP

Watch this session:


Federal/State Election Impacts and Legislative Initiatives for Marijuana and CBD Regulation
William A. Garvin, Shareholder, Buchanan Ingersoll & Rooney PC
Jonathan A. Havens
, Partner, Saul Ewing Arnstein & Lehr LLP
Justin Strekal, Political Director, National Organization for the Reform of Marijuana Laws – NORML
Moderated by Paul Demko, Cannabis Editor, Politico

Watch this session:

CBD Regulatory Updates
Douglas MacKay
, SVP, Scientific and Regulatory Affairs, CV Sciences
Brian J. Malkin
, Partner, McDermott Will & Emery
Christopher Van Gundy
, Partner, Sheppard Mullin Richter & Hampton LLP

Watch this session:


Navigating Drug Preclusion Gaps for Food and Dietary Supplements Containing CBD and Other Cannabinoids
Brad Douglass, Independent Consultant, EAS Consulting Group
Jensen Jose, Regulatory Counsel, Center for Science in the Public Interest
Megan L. Olsen, VP & Associate General Counsel, Council for Responsible Nutrition
Moderated by Robert Durkin, Of Counsel, Arnall Golden Gregory LLP

Watch this session:


U.S. DOJ, DEA, and FTC Approaches to Marijuana and CBD Regulation and Enforcement
John Claud, Assistant Director, Consumer Protection Branch, US Department of Justice
Richard Cleland, Assistant Director, Bureau of Consumer Protection, Division of Advertising Practices, Federal Trade Commission
Moderated by Tom Firestone, Partner, Baker McKenzie

Watch session here:

Wednesday, December 9

FDLI Welcome and Introduction
Laura A. Brown, Director, Educational Programs, FDLI

Regulatory and Practical Research Limitations and Solutions for Cannabis-Derived Products

Deborah Miran, Consultant, DMiran Consulting
Heike Newman, Senior Regulatory Manager, University of Colorado
Evelina Norwinski, Partner, Arnold & Porter LLP

Watch this session:

To IND or Not IND: That is the Question for CBD and Marijuana Products

Rodney William Butt, Senior Vice President – Strategic Solutions, Nutrasource Pharmaceutical & Nutraceutical Services
Kelly Fair, US General Counsel, VP US & European Affairs, Canopy Growth Corporation
Alice P. Mead, Senior Advisor, Greenwich Biosciences
Moderated by Tish E. Pahl, Partner, Olsson Frank Weeda Terman Matz PC

Watch this session:


Concurrent Breakout Sessions

  • Managing Biomass and Biowaste from the Hemp and Cannabis Industries

Keith Matthews, Of Counsel, Wiley LLP
Stephanie McGraw, Partner, Shook, Hardy & Bacon LLP

Watch this session:


  • State Quality Issues for Marijuana and CBD

Tara Lin Couch, Senior Director for Dietary Supplement and Tobacco Services, EAS Consulting Group
Andrew Freedman, Director of Cannabis Coordination, State of Colorado (former), Senior Vice President, Forbes Tate Partners
Darwin Millard, Member, ASTM International Technical Committee D37 on Cannabis, and owner, TSOC LLC

Watch this session:


The Patchwork Quilt of State Hemp Laws

Mai T. Dinh, Assistant General Counsel, Marketing, Regulatory, and Food Safety Programs, Division Office of the General Counsel, USDA
Daniel R. Dwyer, Partner, Kleinfeld, Kaplan & Becker, LLP
Steven N. Levine, Partner, Husch Blackwell LLP

Watch this session:


International Cannabis Regulation and Market Opportunities

Michael Krawitz, Executive Director, Veterans for Medical Cannabis Access, Serving as a Civil Society Focal Point, World Health Organization, Expert Committee on Drug Dependance, Cannabis Critical Review Process
Eileen M. McMahon
, Senior Partner, Torys LLP

Watch this session: